Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

2.

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S.

J Urol. 2012 Oct;188(4):1108-13. doi: 10.1016/j.juro.2012.06.018. Epub 2012 Aug 15.

PMID:
22901581
[PubMed - indexed for MEDLINE]
3.

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.

Shelley M, Cleves A, Wilt TJ, Mason M.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD008976. doi: 10.1002/14651858.CD008976.pub2. Review.

PMID:
21491413
[PubMed - indexed for MEDLINE]
4.

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N.

Int J Clin Oncol. 2013 Aug;18(4):724-30. doi: 10.1007/s10147-012-0447-z. Epub 2012 Jul 19.

PMID:
23011100
[PubMed - indexed for MEDLINE]
5.

Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.

Shelley MD, Cleves A, Wilt TJ, Mason MD.

BJU Int. 2011 Jul;108(2):168-79. doi: 10.1111/j.1464-410X.2011.10341.x. Review.

PMID:
21718430
[PubMed - indexed for MEDLINE]
6.
7.

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.

Linardou H, Aravantinos G, Efstathiou E, Kalofonos C, Anagnostopoulos A, Deliveliotis C, Bafaloukos D, Athanasios Dimopoulos M, Bamias A; Phase II study of Hellenic Co-operative Oncology Group.

Urology. 2004 Sep;64(3):479-84.

PMID:
15351574
[PubMed - indexed for MEDLINE]
8.

Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.

Park JH, Lee SW, Kim HS, Kang SG, Ko YH, Kim ST, Kang SH, Park YJ, Choi IK, Oh SC, Sung DJ, Seo JH, Cheon J, Kim YH, Kim JS, Park KH.

Cancer Chemother Pharmacol. 2013 Apr;71(4):1033-9. doi: 10.1007/s00280-013-2098-9. Epub 2013 Feb 1.

PMID:
23370665
[PubMed - indexed for MEDLINE]
9.

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.

Bamias A, Moulopoulos LA, Koutras A, Aravantinos G, Fountzilas G, Pectasides D, Kastritis E, Gika D, Skarlos D, Linardou H, Kalofonos HP, Dimopoulos MA.

Cancer. 2006 Jan 15;106(2):297-303.

PMID:
16342065
[PubMed - indexed for MEDLINE]
Free Article
10.

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.

Weight CJ, Garcia JA, Hansel DE, Fergany AF, Campbell SC, Gong MC, Jones JS, Klein EA, Dreicer R, Stephenson AJ.

Cancer. 2009 Feb 15;115(4):792-9. doi: 10.1002/cncr.24106.

PMID:
19127557
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.

Sauer R, Birkenhake S, Kühn R, Wittekind C, Schrott KM, Martus P.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):121-7.

PMID:
9422567
[PubMed - indexed for MEDLINE]
12.

Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.

Iwasaki K, Obara W, Kato Y, Takata R, Tanji S, Fujioka T.

Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.

PMID:
23275643
[PubMed - indexed for MEDLINE]
Free Article
13.

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

Yeshchina O, Badalato GM, Wosnitzer MS, Hruby G, RoyChoudhury A, Benson MC, Petrylak DP, McKiernan JM.

Urology. 2012 Feb;79(2):384-90. doi: 10.1016/j.urology.2011.10.050. Epub 2011 Dec 22.

PMID:
22196406
[PubMed - indexed for MEDLINE]
14.

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.

Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.

J Urol. 1995 Jan;153(1):47-52.

PMID:
7966789
[PubMed - indexed for MEDLINE]
15.

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.

Liew MS, Azad A, Tafreshi A, Eapen R, Bolton D, Davis ID, Sengupta S.

BJU Int. 2013 Nov;112 Suppl 2:74-82. doi: 10.1111/bju.12384.

PMID:
24127680
[PubMed - indexed for MEDLINE]
16.

Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.

Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.

Int J Urol. 2008 Apr;15(4):314-8. doi: 10.1111/j.1442-2042.2008.02000.x.

PMID:
18380818
[PubMed - indexed for MEDLINE]
17.

Current and future perspectives in advanced bladder cancer: is there a new standard?

von der Maase H.

Semin Oncol. 2002 Feb;29(1 Suppl 3):3-14. Review.

PMID:
11894002
[PubMed - indexed for MEDLINE]
18.

Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment.

Bamias A, Lainakis G, Kastritis E, Antoniou N, Alivizatos G, Koureas A, Chrisofos M, Skolarikos A, Karayiotis E, Dimopoulos MA.

Oncology. 2007;73(5-6):290-7. doi: 10.1159/000132394. Epub 2008 May 14.

PMID:
18477854
[PubMed - indexed for MEDLINE]
19.

Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.

Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY, Chang PL, Chu SH, Wu CT, Hong JH.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):726-33.

PMID:
12788178
[PubMed - indexed for MEDLINE]
20.

Induction chemotherapy for unresectable urothelial carcinoma of the bladder.

Ghadjar P, Burkhard FC, Gautschi O, Thalmann GN, Studer UE.

BJU Int. 2011 Mar;107(6):894-7. doi: 10.1111/j.1464-410X.2010.09574.x. Epub 2010 Sep 14.

PMID:
20840547
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk